Clinical Research Fellow

London, United Kingdom

Job Description

About us
The Division reaching across three London campuses (Bloomsbury, Royal Free and Stanmore) brings together three major research departments; Tissue and Energy, Nanotechnology and Materials and Tissue. Within these departments are world class research centres, specialising in many different surgical and interventional specialties.
About the role
The Prostate Cancer Unit at UCL has carried out unprecedented work over the years, transforming our understanding of this disease and the global approaches to diagnosing and treating it. Founded by Professor Mark Emberton, UCL prostate cancer researchers discovered the benefits of using magnetic resonance imaging (MRI) scanners for prostate cancer diagnosis. Proved to be efficient and non-invasive, this discovery has doubled the accuracy of prostate cancer diagnosis, allowing thousands of men a year to avoid an unnecessary biopsy. Few institutions have the expertise, history of success and specialist infrastructure to carry out the pioneering research and clinical trials needed to drive forward research in prostate cancer today. At UCL we are world leader in prostate MRI and two key studies of the last 10 years (PROMIS, PRECISION and PRIME trials) have been successfully led by our group of researchers and clinicians.
This job is ideal for a pre-CCT doctor in training or returning to training after the research post. Post-CCT doctors are welcome to apply but it would be funded pro rata as per their consultant salary scale and be dependent on undertaking joint employment as per the Follett principles.
Other

  • The advert will close on 12 November 2025 at 23:59 GMT, however we may close applications early if we receive a high volume of applications. Early application submission is recommended.
  • Interview Date(s) TBC
  • The UCL Ways of Working supports colleagues to be successful and happy at UCL through sharing expectations around how we work - please visit
to find out more.
About you
The post holder must hold a Medical Degree (MD, MC ChB or equivalent).
GMC registration (Non UK trained applicants must supply at interview evidence of eligibility for full GMC registration)
Knowledge of prostate cancer, its presentation, diagnosis, available options and treatment side-effect profile would be advantageous.
The successful candidate must have an experience in publishing in peer-reviewed medical journals.
Willingness to write papers collaboratively and present results at conferences if required.
What we offer
As well as the exciting opportunities this role presents, we also offer some great benefits some of which are below:
  • 41 Days holiday (27 days annual leave 8 bank holiday and 6 closure days)
  • Additional 5 days' annual leave purchase scheme
  • Defined benefit career average revalued earnings pension scheme (CARE)
  • Cycle to work scheme and season ticket loan
  • Immigration loan
  • Relocation scheme for certain posts
  • On-Site nursery
  • On-site gym
  • Enhanced maternity, paternity and adoption pay
  • Employee assistance programme: Staff Support Service
  • Discounted medical insurance
Our commitment to Equality, Diversity and Inclusion
As London's Global University, we know diversity fosters creativity and innovation, and we want our community to represent the diversity of the world's talent. We are committed to equality of opportunity, to being fair and inclusive, and to being a place where we all belong. We therefore particularly encourage applications from candidates who are likely to be underrepresented in UCL's workforce.
Customer advert reference: B02-09333

Skills Required

Beware of fraud agents! do not pay money to get a job

MNCJobs.co.uk will not be responsible for any payment made to a third-party. All Terms of Use are applicable.


Job Detail

  • Job Id
    JD3779294
  • Industry
    Not mentioned
  • Total Positions
    1
  • Job Type:
    Full Time
  • Salary:
    £45,943-57,397 per year
  • Employment Status
    Permanent
  • Job Location
    London, United Kingdom
  • Education
    Not mentioned